// App-Quantinova.ai

: Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS

Researchers

Presenter

  • Norbert Krug

Principal Investigators

  • Jens M. Hohlfeld

  • Antonios Aliprantis

  • Leonidas Carayannopoulos

  • An Bautmans

  • Martine Robberechts

  • Inge De Lepeleire

  • Holger Ziehr

  • Dave Singh

  • Zuzana Diamant

  • Shan Yang

  • Neil Fitch

  • Bob Thornton

  • Peter J. Sterk

Medical Centers

  • Fraunhofer ITEM, Hannover, Germany,

  • Merck Research Laboratories, Kenilworth, New Jersey, United States

  • MSD Research Laboratories, Brussels, Belgium

  • Fraunhofer ITEM, Braunschweig, Germany

  • Medicines Evaluation Unit, Manchester, United Kingdom.

  • Lund University Hospital, Lund, Sweden

  • BioSciConsulting, Maasmechelen, Belgium,

  • University of Amsterdam, Amsterdam, Netherlands

Locations

  • Germany

  • United States

  • Belgium

  • United Kingdom

  • Sweden

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • Glomeruloid microvascular proliferation

Drug/Treatment

  • RV16UB

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved